Physician profile
Jerry White
NPI 1245655968
$6,797.84
in general payments reported to CMS, 2019-2025
30 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $208 · 2021: $1,109 · 2022: $907 · 2023: $1,406 · 2024: $1,351 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,947.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,940.15 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,347.60 | 2020-2025 | Lifevest |
| Pfizer INC. | $738.33 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $614.77 | 2019-2024 | Farxiga, Andexxa |
| Cvrx, INC. | $291.31 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $255.05 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $184.36 | 2021-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.80 | 2021-2024 | Jardiance |
| Amgen INC. | $156.21 | 2019-2023 | Repatha |
| Philips North America LLC | $140.18 | 2023-2024 | (9278) Bridge, (Ak6) Vest Therapy |
| Janssen Pharmaceuticals, INC | $135.04 | 2021-2022 | |
| Boston Scientific Corporation | $112.26 | 2022-2024 | Watchman Access System |
| Merck Sharp & Dohme LLC | $111.75 | 2021-2025 | Verquvo |
| United Therapeutics Corporation | $87.68 | 2024-2025 | Tyvaso, Tyvaso |
| Novo Nordisk INC | $80.43 | 2024-2025 | Wegovy, Ozempic |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $76.14 | 2021 | |
| Inspire Medical Systems, INC. | $50.15 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $45.15 | 2024 | Dupixent, Evkeeza |
| Esperion Therapeutics, INC. | $36.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.14 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $28.69 | 2022 | |
| Mylan Specialty L.P. | $27.42 | 2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $21.80 | 2020 | |
| Viatris Specialty LLC | $20.50 | 2025 | Yupelri |
| Shockwave Medical, INC | $17.05 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $15.28 | 2023 | Linq II |
| Zoll Circulation INC | $14.65 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Medtronic Vascular, INC. | $13.94 | 2020 | |
| Siemens Medical Solutions USA, INC. | $13.63 | 2020 | |
| Convatec INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.